Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft

Creative Commons License

Aldemir M., Keles I., Karalar M., Tecer E., Adali F., Pektas M. B., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.16, no.2, pp.131-136, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.5152/akd.2015.5936
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.131-136
  • Kütahya Health Sciences University Affiliated: No

Abstract

Objective: The aim of this study was to evaluate erectile function in males undergoing coronary artery bypass graft (CABG) while on two different adrenoceptor beta-blocker regimens, namely nebivolol and metoprolol. We hypothesize that the negative effects of cardiopulmonary bypass on erectile function may be possibly attenuated by preferring a vasodilating selective beta(1)-blocker, nebivolol, to metoprolol as an anti-ischemic and antiarrhythmic agent in males undergoing CABG.